177 related articles for article (PubMed ID: 14694210)
1. Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin.
Bagnasco M; Dube MG; Katz A; Kalra PS; Kalra SP
Obes Res; 2003 Dec; 11(12):1463-70. PubMed ID: 14694210
[TBL] [Abstract][Full Text] [Related]
2. Central leptin gene therapy blocks high-fat diet-induced weight gain, hyperleptinemia, and hyperinsulinemia: increase in serum ghrelin levels.
Dube MG; Beretta E; Dhillon H; Ueno N; Kalra PS; Kalra SP
Diabetes; 2002 Jun; 51(6):1729-36. PubMed ID: 12031959
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy.
Bagnasco M; Dube MG; Kalra PS; Kalra SP
Endocrinology; 2002 Nov; 143(11):4409-21. PubMed ID: 12399438
[TBL] [Abstract][Full Text] [Related]
4. Long-term suppression of weight gain, adiposity, and serum insulin by central leptin gene therapy in prepubertal rats: effects on serum ghrelin and appetite-regulating genes.
Beretta E; Dube MG; Kalra PS; Kalra SP
Pediatr Res; 2002 Aug; 52(2):189-98. PubMed ID: 12149495
[TBL] [Abstract][Full Text] [Related]
5. Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study.
Dhillon H; Kalra SP; Prima V; Zolotukhin S; Scarpace PJ; Moldawer LL; Muzyczka N; Kalra PS
Regul Pept; 2001 Jun; 99(2-3):69-77. PubMed ID: 11384767
[TBL] [Abstract][Full Text] [Related]
6. Central leptin gene therapy blocks ovariectomy-induced adiposity.
Torto R; Boghossian S; Dube MG; Kalra PS; Kalra SP
Obesity (Silver Spring); 2006 Aug; 14(8):1312-9. PubMed ID: 16988073
[TBL] [Abstract][Full Text] [Related]
7. Increased leptin expression in the dorsal vagal complex suppresses adiposity without affecting energy intake and metabolic hormones.
Boghossian S; Lecklin A; Dube MG; Kalra PS; Kalra SP
Obesity (Silver Spring); 2006 Jun; 14(6):1003-9. PubMed ID: 16861605
[TBL] [Abstract][Full Text] [Related]
8. Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy.
Ueno N; Dube MG; Inui A; Kalra PS; Kalra SP
Endocrinology; 2004 Sep; 145(9):4176-84. PubMed ID: 15155574
[TBL] [Abstract][Full Text] [Related]
9. Central leptin gene therapy fails to overcome leptin resistance associated with diet-induced obesity.
Wilsey J; Zolotukhin S; Prima V; Scarpace PJ
Am J Physiol Regul Integr Comp Physiol; 2003 Nov; 285(5):R1011-20. PubMed ID: 14557234
[TBL] [Abstract][Full Text] [Related]
10. Urocortin in the hypothalamic PVN increases leptin and affects uncoupling proteins-1 and -3 in rats.
Kotz CM; Wang C; Levine AS; Billington CJ
Am J Physiol Regul Integr Comp Physiol; 2002 Feb; 282(2):R546-51. PubMed ID: 11792665
[TBL] [Abstract][Full Text] [Related]
11. Obesity and metabolic syndrome: long-term benefits of central leptin gene therapy.
Kalra PS; Kalra SP
Drugs Today (Barc); 2002 Nov; 38(11):745-57. PubMed ID: 12582458
[TBL] [Abstract][Full Text] [Related]
12. Central LIF gene therapy suppresses food intake, body weight, serum leptin and insulin for extended periods.
Beretta E; Dhillon H; Kalra PS; Kalra SP
Peptides; 2002 May; 23(5):975-84. PubMed ID: 12084530
[TBL] [Abstract][Full Text] [Related]
13. Central pro-opiomelanocortin gene delivery results in hypophagia, reduced visceral adiposity, and improved insulin sensitivity in genetically obese Zucker rats.
Li G; Mobbs CV; Scarpace PJ
Diabetes; 2003 Aug; 52(8):1951-7. PubMed ID: 12882910
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic pro-opiomelanocortin gene delivery ameliorates obesity and glucose intolerance in aged rats.
Li G; Zhang Y; Wilsey JT; Scarpace PJ
Diabetologia; 2005 Nov; 48(11):2376-85. PubMed ID: 16205885
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of CART in the PVN increases food intake and weight gain in rats.
Smith KL; Gardiner JV; Ward HL; Kong WM; Murphy KG; Martin NM; Ghatei MA; Bloom SR
Obesity (Silver Spring); 2008 Oct; 16(10):2239-44. PubMed ID: 18719668
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus.
Dhillon H; Kalra SP; Kalra PS
Mol Ther; 2001 Aug; 4(2):139-45. PubMed ID: 11482985
[TBL] [Abstract][Full Text] [Related]
17. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.
Stofkova A; Skurlova M; Kiss A; Zelezna B; Zorad S; Jurcovicova J
Endocr Regul; 2009 Jul; 43(3):99-106. PubMed ID: 19817504
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of leptin expression and function in A/J vs. C57BL/6J mice during diet-induced obesity.
Watson PM; Commins SP; Beiler RJ; Hatcher HC; Gettys TW
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E356-65. PubMed ID: 10913036
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin regulates adiposity in white adipose tissue and UCP1 mRNA expression in brown adipose tissue in mice.
Tsubone T; Masaki T; Katsuragi I; Tanaka K; Kakuma T; Yoshimatsu H
Regul Pept; 2005 Aug; 130(1-2):97-103. PubMed ID: 15946750
[TBL] [Abstract][Full Text] [Related]
20. Paraventricular nucleus-microinjected glucose increases food intake in 18 h food-deprived rats: A central regulatory mechanism on serum ghrelin and leptin levels.
Brojeni MS; Nasseri F; Haghparast A; Eliassi A
Eur J Pharmacol; 2020 Jun; 876():173073. PubMed ID: 32188577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
